NCT00003892 ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00003887 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00003880 Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00003852 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors Status TERMINATED Phase PHASE2
NCT00003811 Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT00003794 Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Status TERMINATED Phase N/A
NCT00003778 Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT00003733 Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer Status UNKNOWN Phase PHASE2
NCT00003732 Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00003718 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Status UNKNOWN Phase PHASE2
NCT00003695 Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer Status COMPLETED Phase PHASE3
NCT00003670 Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00003644 Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer Status COMPLETED Phase PHASE3